Last reviewed · How we verify
Ketamine nebulizer
At a glance
| Generic name | Ketamine nebulizer |
|---|---|
| Sponsor | Sohag University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparison of Nebulized Ketamine With Nebulized Magnesium Sulfate for the Prevention of Postoperative Sore Throat (NA)
- Nebulized Sub-dissociative Dose Ketamine at Three Different Dosing Regimens for Treating Acute Pain in the Pediatric ED (PHASE4)
- Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations (PHASE2)
- Comparing Nebulized Ketamine,Nebulized Ketamine and Precedex and IM Ketamine for Analgesia in Pediatric Burn (PHASE1)
- Nebulized vs. IV Ketamine in Preventing Shivering Post Spinal Anesthesia (NA)
- Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting (PHASE3)
- Comparison of Nebulized Ketamine to Intravenous Sub-Dissociative Dose Ketamine for Pain (PHASE4)
- A Comparative Evaluation of Nebulized Dexmedetomidine and Nebulized Ketamine as a Premedication in Pediatric Surgeries (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ketamine nebulizer CI brief — competitive landscape report
- Ketamine nebulizer updates RSS · CI watch RSS
- Sohag University portfolio CI